These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25620627)

  • 1. Optimizing the order of hypotheses in serial testing of multiple endpoints in clinical trials.
    Zhang Z; Wang C; Troendle JF
    Stat Med; 2015 Apr; 34(9):1467-82. PubMed ID: 25620627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On testing simultaneously non-inferiority in two multiple primary endpoints and superiority in at least one of them.
    Röhmel J; Gerlinger C; Benda N; Läuter J
    Biom J; 2006 Dec; 48(6):916-33. PubMed ID: 17240652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A graphical approach to sequentially rejective multiple test procedures.
    Bretz F; Maurer W; Brannath W; Posch M
    Stat Med; 2009 Feb; 28(4):586-604. PubMed ID: 19051220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning.
    Schmidt R; Burkhardt B; Faldum A
    Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resampling in multiple-dose factorial designs.
    Frommolt P; Hellmich M
    Biom J; 2009 Dec; 51(6):915-31. PubMed ID: 20029896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepwise gatekeeping procedures in clinical trial applications.
    Dmitrienko A; Tamhane AC; Wang X; Chen X
    Biom J; 2006 Dec; 48(6):984-91. PubMed ID: 17240656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating co-primary endpoints collectively in clinical trials.
    Li QH
    Biom J; 2009 Feb; 51(1):137-45. PubMed ID: 19219905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplicity adjustment for multiple endpoints in clinical trials with multiple doses of an active treatment.
    Quan H; Luo X; Capizzi T
    Stat Med; 2005 Jul; 24(14):2151-70. PubMed ID: 15909290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of multiple ordinal endpoints.
    Häberle L; Pfahlberg A; Gefeller O
    Biom J; 2009 Feb; 51(1):217-26. PubMed ID: 19197963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new partition testing strategy for multiple endpoints.
    Wang B; Cui X
    Stat Med; 2012 Sep; 31(20):2151-68. PubMed ID: 22532094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Power and sample size when multiple endpoints are considered.
    Senn S; Bretz F
    Pharm Stat; 2007; 6(3):161-70. PubMed ID: 17674404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weighted multiple testing correction for correlated tests.
    Xie C
    Stat Med; 2012 Feb; 31(4):341-52. PubMed ID: 22114000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A convenient formula for sample size calculations in clinical trials with multiple co-primary continuous endpoints.
    Sugimoto T; Sozu T; Hamasaki T
    Pharm Stat; 2012; 11(2):118-28. PubMed ID: 22415870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The analysis of multiple endpoints in clinical trials.
    Pocock SJ; Geller NL; Tsiatis AA
    Biometrics; 1987 Sep; 43(3):487-98. PubMed ID: 3663814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Power and sample size for clinical trials when efficacy is required in multiple endpoints: application to an Alzheimer's treatment trial.
    Xiong C; Yu K; Gao F; Yan Y; Zhang Z
    Clin Trials; 2005; 2(5):387-93. PubMed ID: 16317808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sample size determination in clinical trials with multiple co-primary endpoints including mixed continuous and binary variables.
    Sozu T; Sugimoto T; Hamasaki T
    Biom J; 2012 Sep; 54(5):716-29. PubMed ID: 22829198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The likelihood as statistical evidence in multiple comparisons in clinical trials: no free lunch.
    Korn EL; Freidlin B
    Biom J; 2006 Jun; 48(3):346-55. PubMed ID: 16845900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size determination in clinical trials with multiple co-primary binary endpoints.
    Sozu T; Sugimoto T; Hamasaki T
    Stat Med; 2010 Sep; 29(21):2169-79. PubMed ID: 20687162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiparametric inference for surrogate endpoints with bivariate censored data.
    Ghosh D
    Biometrics; 2008 Mar; 64(1):149-56. PubMed ID: 17651457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional multiplicity adjustment methods in clinical trials.
    Dmitrienko A; D'Agostino R
    Stat Med; 2013 Dec; 32(29):5172-218. PubMed ID: 24114861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.